Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy

Well-differentiated thyroid cancer (WDTC) is a malignant head and neck tumor with a very high incidence. Thyroidectomized WDTC patients have been referred to nuclear medicine for radioactive iodine (RAI) ablation therapy and/or annual follow-up with diagnostic whole-body imaging. Serum thyroglobulin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hashem O. Zahra, Gamal A. Omran, Ahmed G. Gewely, Ahmed Fathy Eldehn, Walied Abdo, Ehab Kotb Elmahallawy, Tarek M. Okda
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2c6908eea1034a4d8a0be85031e35b85
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2c6908eea1034a4d8a0be85031e35b85
record_format dspace
spelling oai:doaj.org-article:2c6908eea1034a4d8a0be85031e35b852021-11-25T17:21:27ZPrognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy10.3390/diagnostics111120802075-4418https://doaj.org/article/2c6908eea1034a4d8a0be85031e35b852021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2080https://doaj.org/toc/2075-4418Well-differentiated thyroid cancer (WDTC) is a malignant head and neck tumor with a very high incidence. Thyroidectomized WDTC patients have been referred to nuclear medicine for radioactive iodine (RAI) ablation therapy and/or annual follow-up with diagnostic whole-body imaging. Serum thyroglobulin (TG) and thyroglobulin antibodies (TGAb) are biochemical tumor markers used to monitor WDTC. A global rise in the prevalence of WDTC is increasing the number of thyroidectomized patients requiring lifelong monitoring for persistent or recurrent diseases. The present study aimed to identify the most successful prognostic factors in well-defined thyroid carcinoma patients following total thyroidectomy and RAI therapy, followed by an estimation of the cutoff value of TG and TGAb. In this context, a total of 100 subjects were recruited and classified as follows: 60 thyroid carcinoma patients underwent total thyroidectomy and successful RAI therapy, while 40 normal healthy individuals matched for age, sex, and socioeconomic status constituted the control group. Interestingly, the levels of TG did not differ significantly between the relapsed and non-relapsed cases, but the levels of TGAb differed significantly between the relapsed and non-relapsed cases. Collectively, TG and TGAb are considered the most successful prognostic factors in well-defined thyroid carcinoma patients after total thyroidectomy and RAI therapy. The present study also concluded that the TGAb determination was better than that of the TG level, with a cutoff value of 10 ng/mL. These findings provide baseline information for follow-up and lifelong monitoring of thyroidectomized WDTC patients. Further research is warranted to explore more about serum TG and TGAb in thyroid carcinoma patients on a larger scale.Hashem O. ZahraGamal A. OmranAhmed G. GewelyAhmed Fathy EldehnWalied AbdoEhab Kotb ElmahallawyTarek M. OkdaMDPI AGarticleWDTCthyroid carcinomathyroglobulinanti-thyroglobulin antibodythyroid transcription factor 1Medicine (General)R5-920ENDiagnostics, Vol 11, Iss 2080, p 2080 (2021)
institution DOAJ
collection DOAJ
language EN
topic WDTC
thyroid carcinoma
thyroglobulin
anti-thyroglobulin antibody
thyroid transcription factor 1
Medicine (General)
R5-920
spellingShingle WDTC
thyroid carcinoma
thyroglobulin
anti-thyroglobulin antibody
thyroid transcription factor 1
Medicine (General)
R5-920
Hashem O. Zahra
Gamal A. Omran
Ahmed G. Gewely
Ahmed Fathy Eldehn
Walied Abdo
Ehab Kotb Elmahallawy
Tarek M. Okda
Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
description Well-differentiated thyroid cancer (WDTC) is a malignant head and neck tumor with a very high incidence. Thyroidectomized WDTC patients have been referred to nuclear medicine for radioactive iodine (RAI) ablation therapy and/or annual follow-up with diagnostic whole-body imaging. Serum thyroglobulin (TG) and thyroglobulin antibodies (TGAb) are biochemical tumor markers used to monitor WDTC. A global rise in the prevalence of WDTC is increasing the number of thyroidectomized patients requiring lifelong monitoring for persistent or recurrent diseases. The present study aimed to identify the most successful prognostic factors in well-defined thyroid carcinoma patients following total thyroidectomy and RAI therapy, followed by an estimation of the cutoff value of TG and TGAb. In this context, a total of 100 subjects were recruited and classified as follows: 60 thyroid carcinoma patients underwent total thyroidectomy and successful RAI therapy, while 40 normal healthy individuals matched for age, sex, and socioeconomic status constituted the control group. Interestingly, the levels of TG did not differ significantly between the relapsed and non-relapsed cases, but the levels of TGAb differed significantly between the relapsed and non-relapsed cases. Collectively, TG and TGAb are considered the most successful prognostic factors in well-defined thyroid carcinoma patients after total thyroidectomy and RAI therapy. The present study also concluded that the TGAb determination was better than that of the TG level, with a cutoff value of 10 ng/mL. These findings provide baseline information for follow-up and lifelong monitoring of thyroidectomized WDTC patients. Further research is warranted to explore more about serum TG and TGAb in thyroid carcinoma patients on a larger scale.
format article
author Hashem O. Zahra
Gamal A. Omran
Ahmed G. Gewely
Ahmed Fathy Eldehn
Walied Abdo
Ehab Kotb Elmahallawy
Tarek M. Okda
author_facet Hashem O. Zahra
Gamal A. Omran
Ahmed G. Gewely
Ahmed Fathy Eldehn
Walied Abdo
Ehab Kotb Elmahallawy
Tarek M. Okda
author_sort Hashem O. Zahra
title Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
title_short Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
title_full Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
title_fullStr Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
title_full_unstemmed Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
title_sort prognostic value of serum thyroglobulin and anti-thyroglobulin antibody in thyroid carcinoma patients following thyroidectomy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2c6908eea1034a4d8a0be85031e35b85
work_keys_str_mv AT hashemozahra prognosticvalueofserumthyroglobulinandantithyroglobulinantibodyinthyroidcarcinomapatientsfollowingthyroidectomy
AT gamalaomran prognosticvalueofserumthyroglobulinandantithyroglobulinantibodyinthyroidcarcinomapatientsfollowingthyroidectomy
AT ahmedggewely prognosticvalueofserumthyroglobulinandantithyroglobulinantibodyinthyroidcarcinomapatientsfollowingthyroidectomy
AT ahmedfathyeldehn prognosticvalueofserumthyroglobulinandantithyroglobulinantibodyinthyroidcarcinomapatientsfollowingthyroidectomy
AT waliedabdo prognosticvalueofserumthyroglobulinandantithyroglobulinantibodyinthyroidcarcinomapatientsfollowingthyroidectomy
AT ehabkotbelmahallawy prognosticvalueofserumthyroglobulinandantithyroglobulinantibodyinthyroidcarcinomapatientsfollowingthyroidectomy
AT tarekmokda prognosticvalueofserumthyroglobulinandantithyroglobulinantibodyinthyroidcarcinomapatientsfollowingthyroidectomy
_version_ 1718412458945675264